PMC:7441777 / 547-832
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T3 | 63-66 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T4 | 77-80 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T5 | 120-123 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
T6 | 282-285 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T6 | 53-61 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T7 | 109-117 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T8 | 34-42 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
T9 | 172-186 | Chemical | denotes | antiviral drug | http://purl.obolibrary.org/obo/CHEBI_36044 |
T10 | 172-181 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T11 | 182-186 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
T12 | 232-243 | Chemical | denotes | polyphenols | http://purl.obolibrary.org/obo/CHEBI_26195 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 120-135 | http://purl.obolibrary.org/obo/GO_0039703 | denotes | RNA replication |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
44 | 93-97 | Gene | denotes | RdRp | Gene:43740578 |
45 | 268-272 | Gene | denotes | RdRp | Gene:43740578 |
56 | 109-119 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
58 | 232-243 | Chemical | denotes | polyphenols | MESH:D059808 |
78 | 53-61 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T10 | 63-194 | Sentence | denotes | RNA‐dependent RNA polymerase (RdRp) catalyzes SARS-CoV-2 RNA replication and hence, is an obvious target for antiviral drug design. |